Cdc2 p34 (B-5) Antibody sc-137035 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCdc2 p34 (B-5) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-137035
NCBI Gene AliasesCDC28A, p34<CDC2>, P34CDC2, CDC2, Cdc2, Cdc2a
Antibody TypePrimary Antibodies
Quantity200 µg/ml
CloneB-5
ApplicationsWB, IP, IF, IHC(P), ELISA
Reactivitymouse, rat, human
ClonalityMonoclonal
Conjugate/TagUnconjugated
FormatPurified
Hostmouse
NCBI Full Gene Namecyclin dependent kinase 1
TargetCdc2 p34
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2-M checkpoint modulationCancer medicineMay 1, 2021Cao Y, Gao A, Li X, Min H, He C, Sun X, Ding WQ, Zhou J.detected as a loading control. All primary antibodies were commercial products. Anti‐TAB182, anti‐CDC2 (sc‐137035), anti‐phospho‐CDC2 (sc‐136014) were purchased from Santa Cruz. Anti‐FHL2 was purchased from Proteintech.

(2) Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathwayCell death & diseaseApril 1, 2019Kuang Y, Guo W, Ling J, Xu D, Liao Y, Zhao H, Du X, Wang H, Xu M, Song H, et al.incubated at room temperature for 1 h. ECL kit (Millipore) was used for Chemiluminescence31. CDK1 (sc-8395, sc-137035) and GP130 (sc-655) primary antibody were purchased from Santa cruz. p-STAT3 (#9145), STAT3 (#9139),

(3) Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potentialCell death and differentiationJuly 1, 2018Gurrapu S, Pupo E, Franzolin G, Lanzetti L, Tamagnone L.

(4) A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityNature communicationsJanuary 17, 2017Xu X, Fan Z, Liang C, Li L, Wang L, Liang Y, Wu J, Chang S, Yan Z, Lv Z, et al.

(5) Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal ruptureExperimental and therapeutic medicineDecember 1, 2016Peng YT, Shi XE, Li ZQ, He X, Sun YM.1:500), p-JNK (sc-293136; 1:500), cyclin B1 (sc-7393; 1:1,000), cyclin D1 (sc-70899; 1:1,000), CDC2 (sc-137035; 1:1,000), ERK (sc-514302; 1: 2,000), p-ERK (sc-101761; 1:1,000,), p38 (sc-4315; 1:1,000) and p-p38

(6) CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor RadioresistanceMolecular cancer therapeuticsSeptember 1, 2015Liu R, Fan M, Candas D, Qin L, Zhang X, Eldridge A, Zou JX, Zhang T, Juma S, Jin C, et al.24h. Antibodies Antibodies used in this study were as follows: The antibodies against β-actin (sc-8432), cdc2 p34 (sc-137035), CyclinB1 (sc-245), p53 (sc-126), SOD-2 (sc-133134), NDUFA9 (sc-58392), phospho-serine (sc-81514),

(7) Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathwayOncology reportsJune 1, 2013Sun KK, Zhong N, Yang Y, Zhao L, Jiao Y.

(8) Anticancer activity of 2α, 3α, 19β, 23β-Tetrahydroxyurs-12-en-28-oic acid (THA), a novel triterpenoid isolated from Sinojackia sarcocarpaPloS oneJanuary 1, 2011Wang O, Liu S, Zou J, Lu L, Chen L, Qiu S, Li H, Lu X.

(9) Neurostatin blocks glioma cell cycle progression by inhibiting EGFR activationMolecular and cellular neurosciencesJanuary 1, 2011Valle-Argos B, Gómez-Nicola D, Nieto-Sampedro M.

Be the First to Write a Review!

Cdc2 p34 (B-5) Antibody

Cdc2 p34 (B-5) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (9)

Reviews

Cdc2 p34 (B-5) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map